----

| ☒ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|---------|--------------------------------------------------------------------------------------|

| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|---------|------------------------------------------------------------------------------------------|

| Delaware                                                                                                                                                                                                                             |   | 98-0469479                                                                                                                                                                                                                                                                                                        |
|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| (State or Other Jurisdiction of Incorporation or Organization)                                                                                                                                                                       |   | (I.R.S. Employer Identification No.)                                                                                                                                                                                                                                                                              |
|                                                                                                                                                                                                                                 |   |                                                                                                                                                                                                                                                                                                              |
|                 1600 Old Country Road, Plainview, NY                 |   |                          11803                          |
| (Address of Principal Executive Offices)                                                                                                                                                                                             |   | (Zip Code)                                                                                                                                                                                                                                                                                                        |
| Title of each class |   | Name of exchange on which registered |
|---------------------|--------|--------------------------------------|
| None                |   |                                 |
| Common Stock     |
|------------------|
| (Title of Class) |

----

| Large accelerated filer                                             | ☐ | Accelerated filer         | ☐ |
|---------------------------------------------------------------------|---------|---------------------------|---------|
| Non-accelerated filer (Do not check if a smaller reporting company) | ☐ | Smaller reporting company | ☒ |
|                                                                |    | Emerging growth company   | ☒ |

----

----

----

|       |     |                                                                                          | Page   |
|------------|----------|-----------------------------------------------------------------------------------------------|--------|
|       |     |                                                                                          |   |
|       |     |                                                                                          |   |
| PART I     |     |                                                                                          | 1      |
|       |     |                                                                                          |   |
|       | ITEM 1.  | Business                                                                                      | 1      |
|       |     |                                                                                          |   |
| PART III   |     |                                                                                          | 1      |
|       |     |                                                                                          |   |
|       | ITEM 10. | Directors, Executive Officers and Corporate Governance                                        | 1      |
|       |     |                                                                                          |   |
|       | ITEM 11. | Executive Compensation                                                                        | 6      |
|       |     |                                                                                          |   |
|       | ITEM 12. | Security Ownership of Certain Beneficial Owners and Managementand Related Stockholder Matters | 9      |
|       |     |                                                                                          |   |
|       | ITEM 13. | Certain Relationships and Related Transactions, and DirectorIndependence                      | 21     |
|       |     |                                                                                          |   |
|       | ITEM 14. | Principal Accounting Fees and Services                                                        | 23     |
|       |     |                                                                                          |   |
| PART IV    |     |                                                                                          | 24     |
|       |     |                                                                                          |   |
|       | ITEM 15. | Exhibits, Financial Statement Schedules                                                       | 24     |
|       |     |                                                                                          |   |
| SIGNATURES | 26       |

----

Table of Contents

| ITEM 1. | Business |
|---------|----------|

| ITEM 10. | Directors, Executive Officers and Corporate Governance |
|----------|--------------------------------------------------------|

----

Table of Contents

----

Table of Contents

| 2017 DIRECTOR COMPENSATION |
|----------------------------|
|                   |   | Fees earned or |   |   |          |   |    |    |   |
|------------------------|--------|----------------|--------|--------|---------------|--------|---------|---------|--------|
|                   |   | paid in cash   |   |   | Stock Awards  |   |    | Total   |   |
| Name                   |   | $         |   |   | $(4)(5)  |   |    | $  |   |
|                   |   |           |   |   |          |   |    |    |   |   |   |   |
| Gabriel A. Battista(1) |   |           | 30,000 |   |          |   | 30,000  |    |   |   | 60,000 |   |
| Shirley Strum Kenny(2) |   |           | 22,500 |   |          |   | 37,500  |    |   |   | 60,000 |   |
| David Kronfeld(3)      |   |           | -      |   |          |   | 80,000  |    |   |   | 80,000 |   |
| Charles B. Wang(3)     |   |           | -      |   |          |   | 50,000  |    |   |   | 50,000 |   |
| Robert E. Bostrom(1)   |   |           | 30,000 |   |          |   | 30,000  |    |   |   | 60,000 |   |
| James R. Hale(3)       |   |           | -      |   |          |   | 65,000  |    |   |   | 65,000 |   |
| John A. Coelho(3)      |   |           | -      |   |          |   | 55,000  |    |   |   | 55,000 |   |
| Edward G. Goren(1)     |   |           | 10,326 |   |          |   | 10,326  |    |   |   | 20,652 |   |
|                   |   |           | 92,826 |   |          |   | 357,826 |    |   |   | 450,652 |   |

| (1) | Messrs. Battista, Bostrom and Goren each elected to receive his director compensation in 2017 as follows:  50% in cash and 50% in Common Stock. |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2) | Dr. Kenny elected to receive her director compensation in 2017 as follows:  In the first half of 2017, 25% in cash and 75% in Common Stock; in the second half of 2017, 50% in cash and 50% in Common Stock. |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (3) | Messrs. Coelho, Hale, Kronfeld and Wang each elected to receive 100% of his 2017 director compensation in Common Stock. |
|-----|-------------------------------------------------------------------------------------------------------------------------|

| (4) | For the fiscal year ended December 31, 2017, non-executive directors earned the following numbers of shares of Common Stock: |
|-----|------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

| Gabriel A. Battista |   |   | 70,658  |   |
|---------------------|--------|--------|---------|--------|
| Shirley Strum Kenny |   |   | 87,815  |   |
| David Kronfeld      |   |   | 188,423 |   |
| Charles B. Wang     |   |   | 117,764 |   |
| Robert E. Bostrom   |   |   | 70,658  |   |
| James R. Hale       |   |   | 153,094 |   |
| John A. Coelho      |   |   | 129,541 |   |
| Edward G. Goren     |   |   | 25,020  |   |
|                |   |   | 842,973 |   |

| (5) | A portion of the director compensation may, at the director’s election, be paid in shares of Common Stock; the value of the below shares is calculated as of the indicated issuance dates and reflected in the Stock Awards column: |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                |   | June 20, 2017 |    |   | December 20, 2017    |   |
|---------------------|--------|---------------|---------|--------|----------------------|--------|
|                |   | Shares        |    |   | Grant date           |   |   | Shares |   |   | Grant date |   |
|                |   | granted       |    |   | fair value per share |   |   | granted |   |   | fair value per share |   |
|                |   | #             |    |   | $                    |   |   | # |   |   | $ |   |
| Gabriel A. Battista |   |          | 34,313  |   |                 |   | 0.437 |   |   |   | 36,345 |   |   |   | 0.413 |   |
| Shirley Strum Kenny |   |          | 51,470  |   |                 |   | 0.437 |   |   |   | 36,345 |   |   |   | 0.413 |   |
| David Kronfeld      |   |          | 91,503  |   |                 |   | 0.437 |   |   |   | 96,920 |   |   |   | 0.413 |   |
| Charles B. Wang     |   |          | 57,189  |   |                 |   | 0.437 |   |   |   | 60,575 |   |   |   | 0.413 |   |
| Robert E. Bostrom   |   |          | 34,313  |   |                 |   | 0.437 |   |   |   | 36,345 |   |   |   | 0.413 |   |
| James R. Hale       |   |          | 74,346  |   |                 |   | 0.437 |   |   |   | 78,748 |   |   |   | 0.413 |   |
| John A. Coelho      |   |          | 62,908  |   |                 |   | 0.437 |   |   |   | 66,633 |   |   |   | 0.413 |   |
| Edward G. Goren     |   |          | N/A     |   |                 |   | N/A |   |   |   | 25,020 |   |   |   | 0.413 |   |
|                |   |          | 406,042 |   |                 |   |   |   |   |   | 436,931 |   |   |   |   |   |

----

Table of Contents

----

Table of Contents

| ITEM 11. | Executive Compensation |
|----------|------------------------|

|                                                             |               |   |   |    |   |   |   |    | Stock  |   |   |    |   |
|------------------------------------------------------------------|--------------------|--------|--------|---------|--------|--------|--------|---------|--------|--------|--------|---------|--------|
|                                                             |     |   | Salary |    |   | Bonus  |   |    | Awards |   |   | Total   |   |
| Name and Principal Position                                      | Year               |   | $      |    |   | $      |   |    | $(4)   |   |   | $       |   |
|                                                             |               |   |   |    |   |   |   |    |   |   |   |    |   |
| Roy E. Reichbach(1)                                              | 2017               |   |   | 350,000 |   |   |   | 150,000 |   |   |   | 334,088 |   |   |   | 834,088 |   |
|    Chief Executive Officer                        | 2016               |   |   | 275,000 |   |   |   | 100,000 |   |   |   | 393,180 |   |   |   | 768,180 |   |
|    Former General Counsel and Corporate Secretary |               |   |   |    |   |   |   |    |   |   |   |    |   |   |   |   |   |
|                                                             |               |   |   |    |   |   |   |    |   |   |   |    |   |   |   |   |   |
| Nancy Li(2)                                                      | 2017               |   |   | 450,000 |   |   |   | 200,000 |   |   |   | 334,088 |   |   |   | 984,088 |   |
|    Executive Chair                                | 2016               |   |   | 450,000 |   |   |   | 200,000 |   |   |   | 491,475 |   |   |   | 1,141,475 |   |
|    Former Executive Vice Chairman                 |               |   |   |    |   |   |   |    |   |   |   |    |   |   |   |   |   |
|                                                             |               |   |   |    |   |   |   |    |   |   |   |    |   |   |   |   |   |
| Michael (Horngwei) Her(3)                                        | 2017               |   |   | 300,000 |   |   |   | 100,000 |   |   |   | 267,270 |   |   |   | 667,270 |   |
|   Chief Technology Officer                             | 2016               |   |   | 300,000 |   |   |   | 100,000 |   |   |   | 393,180 |   |   |   | 793,180 |   |
|   Former Co-Chief Technology Officer                   |               |   |   |    |   |   |   |    |   |   |   |    |   |   |   |   |   |
|                                                             |               |   |   |    |   |   |   |    |   |   |   |    |   |   |   |   |   |
| Ronald Nunn                                                      | 2017               |   |   | 300,000 |   |   |   | 100,000 |   |   |   | 267,270 |   |   |   | 667,270 |   |
|    Executive Vice President,                      | 2016               |   |   | 300,000 |   |   |   | 100,000 |   |   |   | 393,180 |   |   |   | 793,180 |   |
|    Business Operations                            |               |   |   |    |   |   |   |    |   |   |   |    |   |   |   |   |   |
|                                                             |               |   |   |    |   |   |   |    |   |   |   |    |   |   |   |   |   |
| J. Christopher Wagner                                            | 2017               |   |   | 300,000 |   |   |   | 100,000 |   |   |   | 267,270 |   |   |   | 667,270 |   |
|    Executive Vice President,                      | 2016               |   |   | 300,000 |   |   |   | 100,000 |   |   |   | 393,180 |   |   |   | 793,180 |   |
|    Marketplace Strategy                           |               |   |   |    |   |   |   |    |   |   |   |    |   |   |   |   |   |

| (1) | Mr. Reichbach became President and Chief Executive Officer on June 3, 2016.  Prior to that, he served as General Counsel and Corporate Secretary from October 2008. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2) | Ms. Li became Executive Chair on June 3, 2016.  Prior to that, she served as Executive Vice Chairman from January 2015 and as President and Chief Executive Officer from October 2008. |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (3) | Mr. Her became Chief Technology Officer on March 1, 2017.  Prior to that, he served as Co-Chief Technology Officer from January 2015. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------|

| (4) | The amounts reported in the Stock Awards column represent the total fair value of shares of Common Stock issuable upon the future vesting of restricted stock unit awards (“RSU Awards”) (such shares, “Underlying Shares”) granted by the Company to each of the Named Executive Officers, calculated based on the closing fair market value of the Common Stock on the grant date. The grant date fair value of the RSU Awards was determined in accordance with ASC 718, assuming the likely probability of satisfying the performance criteria as determined on the date of grant. The following table sets forth detail corresponding to the total amounts set forth in the Stock Awards column above as it relates to the total fair value of the Underlying Shares issuable pursuant to the RSU Awards granted in 2017 and 2016: |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

|                   |   | 2017 Grants |    |   | 2016 Grants |   |    | Total      |   |
|------------------------|--------|-------------|---------|--------|-------------|--------|---------|------------|--------|
| Name                   |   | Fair Value  |    |   | Fair Value  |   |    | Fair Value |   |
|                   |   | $*          |    |   | $*          |   |    | $*         |   |
| Roy E. Reichbach       |   |        | 334,088 | (a)    |        |   | 393,180 | (c)        |   |   | 727,268 |   |
| Nancy Li               |   |        | 334,088 | (a)    |        |   | 491,475 | (d)        |   |   | 825,563 |   |
| Michael (Horngwei) Her |   |        | 267,270 | (b)    |        |   | 393,180 | (c)        |   |   | 660,450 |   |
| Ronald Nunn            |   |        | 267,270 | (b)    |        |   | 393,180 | (c)        |   |   | 660,450 |   |
| J. Christopher Wagner  |   |        | 267,270 | (b)    |        |   | 393,180 | (c)        |   |   | 660,450 |   |
|   |    |   | Underlying Shares |    |   | Fair Value/Share |   |   | Maximum Shares |   |           | Maximum Value |   |
|--------|--------------|--------|-------------------|---------|--------|------------------|--------|--------|----------------|--------|----------------|---------------|--------|
| Note   | Security     |   |  #           |    |   | $                |   |   | #              |   |           | $             |   |
|   |         |   |              |    |   |             |   |   |           |   |           |          |   |   |   |   |
| (a)    | RSU Award    |   |              | 375,000 |   |             |   | 0.8909 |           |   |           | 500,000       |   |   |   | 445,450 |   |
| (b)    | RSU Award    |   |              | 300,000 |   |             |   | 0.8909 |           |   |           | 400,000       |   |   |   | 356,360 |   |
| (c)    | RSU Award    |   |              | 600,000 |   |             |   | 0.6553 |           |   |   NA      |          |   | NA |   |
| (d)    | RSU Award    |   |              | 750,000 |   |             |   | 0.6553 |           |   |   NA |          |   | NA |   |
|                                                             |   | Option Awards                                        |      |   | Stock Awards           |   |
|------------------------------------------------------------------|--------|------------------------------------------------------|-----------|--------|------------------------|--------|
|                                                             |   |                                                      |      |   |                   |   |   |   |   |   |   |
|                                                             |   |                                                      |      |   |                   |   |    |  |   | Number ofshares or unitsof stock thathave not vested |   |   | Market value ofshares or unitsof stock that have  not vested |   |   | Equityincentive plan awards:number ofunearnedshares, units or other rights  that have notvested |   |   | Equityincentive  planawards:marketvalue ofunearnedshares,units orotherrights thathave notvested |   |
|                                                             |   |                                                      |      |   |                   |   |    |
|                                                             |   | Number of SecuritiesUnderlying UnexercisedOptions(4) |      |   | Option Exercise  Price |   | Option ExpirationDate |
|                                                                  |   | Exercisable                                          |      |   | Unexercisable          |   |
| Name                                                             |   | #                                                    |      |   | #                      |   |   | $ |   |   |   |   | # |   |   | $ |   |   | # |   |   | $ |   |
|                                                             |   |                                                 |      |   |                   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Roy E. Reichbach(1)                                              |   |                                                 | 150,000   |   |                   |   | - |   |   |   | 0.18 |   | 06/04/17 | (5) |   |   | 150,000 | (6) |   |   | 62,174 |   |   |   | 150,000 | (6) |   |   | 62,174 |   |
|    Chief Executive Officer                        |   |                                                 | 750,000   |   |                   |   | - |   |   |   | 0.44 |   | 08/13/23 |   |   |   | 450,000 | (7) |   |   | 186,521 |   |   |   | 450,000 | (7) |   |   | 186,521 |   |
|    Former General Counsel and Corporate Secretary |   |                                                 | 112,500   |   |                   |   | 37,500 |   |   |   | 0.94 |   | 05/12/24 |   |   |   | - |   |   |   | - |   |   |   | 500,000 | (8) |   |   | 207,246 |   |
|                                                             |   |                                                 |      |   |                   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Nancy Li(2)                                                      |   |                                                 | 450,000   |   |                   |   | - |   |   |   | 0.18 |   | 06/04/17 | (5) |   |   | 375,000 | (6) |   |   | 155,435 |   |   |   | 375,000 | (6) |   |   | 155,435 |   |
|    Executive Chair                                |   |                                                 | 900,000   |   |                   |   | - |   |   |   | 0.48 |   | 08/13/18 |   |   |   | 562,500 | (7) |   |   | 233,152 |   |   |   | 562,500 | (7) |   |   | 233,152 |   |
|    Former Executive Vice Chairman                 |   |                                                 | 300,000   |   |                   |   | 100,000 |   |   |   | 1.03 |   | 05/12/19 |   |   |   | - |   |   |   | - |   |   |   | 500,000 | (8) |   |   | 207,246 |   |
|                                                             |   |                                                 |      |   |                   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Michael (Horngwei) Her(3)                                        |   |                                                 | 200,000   |   |                   |   | - |   |   |   | 0.18 |   | 06/04/17 | (5) |   |   | 200,000 | (6) |   |   | 82,898 |   |   |   | 200,000 | (6) |   |   | 82,898 |   |
|    Chief Technology Officer                       |   |                                                 | 1,000,000 |   |                   |   | - |   |   |   | 0.44 |   | 08/13/23 |   |   |   | 450,000 | (7) |   |   | 186,521 |   |   |   | 450,000 | (7) |   |   | 186,521 |   |
|    Former Co-Chief Technology Officer             |   |                                                 | 150,000   |   |                   |   | 50,000 |   |   |   | 0.94 |   | 05/12/24 |   |   |   | - |   |   |   | - |   |   |   | 400,000 | (8) |   |   | 165,797 |   |
|                                                             |   |                                                 |      |   |                   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| Ronald Nunn                                                      |   |                                                 | 200,000   |   |                   |   | - |   |   |   | 0.18 |   | 06/04/17 | (5) |   |   | 200,000 | (6) |   |   | 82,898 |   |   |   | 200,000 | (6) |   |   | 82,898 |   |
|    Executive Vice President,                      |   |                                                 | 1,000,000 |   |                   |   | - |   |   |   | 0.44 |   | 08/13/23 |   |   |   | 450,000 | (7) |   |   | 186,521 |   |   |   | 450,000 | (7) |   |   | 186,521 |   |
|    Business Operations                            |   |                                                 | 150,000   |   |                   |   | 50,000 |   |   |   | 0.94 |   | 05/12/24 |   |   |   | - |   |   |   | - |   |   |   | 400,000 | (8) |   |   | 165,797 |   |
|                                                             |   |                                                 |      |   |                   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
| J. Christopher Wagner                                            |   |                                                 | 50,000    |   |                   |   | - |   |   |   | 0.18 |   | 06/04/17 | (5) |   |   | 100,000 | (6) |   |   | 41,449 |   |   |   | 100,000 | (6) |   |   | 41,449 |   |
|    Executive Vice President,                      |   |                                                 | 1,000,000 |   |                   |   | - |   |   |   | 0.44 |   | 08/13/23 |   |   |   | 450,000 | (7) |   |   | 186,521 |   |   |   | 450,000 | (7) |   |   | 186,521 |   |
|    Marketplace Strategy                           |   |                                                 | 37,500    |   |                   |   | 12,500 |   |   |   | 0.94 |   | 05/12/24 |   |   |   | - |   |   |   | - |   |   |   | 400,000 | (8) |   |   | 165,797 |   |

| (1) | Mr. Reichbach became President and Chief Executive Officer on June 3, 2016.  Prior to that, he served as General Counsel and Corporate Secretary from October 2008. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2) | Ms. Li became Executive Chair on June 3, 2016.  Prior to that, she served as Executive Vice Chairman from January 2015 and as President and Chief Executive Officer from October 2008. |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (3) | Mr. Her became Chief Technology Officer on March 1, 2017.  Prior to that, he served as Co-Chief Technology Officer from January 2015. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

| (4) | Options granted to Ms. Li vest at a rate of one-quarter of their allotted amount per year and are exercisable for a period of five years from the date of grant.  Options granted to Messrs. Reichbach, Her, Nunn and Wagner (i) prior to June 5, 2012 vest at a rate of one-quarter of their allotted amount per year and are exercisable for a period of five years from the date of grant and (ii) since June 5, 2012 vest at a rate of one-quarter of their allotted amount per year and are exercisable for a period of ten years from the date of grant. |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (5) | The expiration date of these options was extended per the terms of the Fourth Amended and Restated Stock Option Plan (“Stock Option Plan”) due to the occurrence of a blackout period.  The options expire 10 business days after the end of such blackout period. |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (6) | These RSU Awards vest in four equal annual installments commencing on the first anniversary of May 18, 2015, the effective grant date. |
|-----|----------------------------------------------------------------------------------------------------------------------------------------|

| (7) | These RSU Awards vest in four equal annual installments commencing on the first anniversary of March 7, 2016, the effective grant date. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------|

| (8) | Represents the number of performance-based RSU Awards granted in February 2017.  When certified for issuance, the RSUs vest in four equal annual installments (on the certification date and on each of the first three anniversaries thereof). |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

| ITEM 12. | Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters |
|----------|------------------------------------------------------------------------------------------------|

| SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT |
|----------------------------------------------------------------|
|                                                           |   |   |   |
|                                                           |   |   |   |
|                                                           | Shares Beneficially |   | Percent of |
| Name and Address of Beneficial Owner(1)                        | Owned(2) |   | Class(3) |
|                                                           |   |   |   |
| Nancy Li                                                       | 81,218,457 | (4) | 28.8% |
| Charles B. Wang                                                | 81,218,457 | (5) | 28.8% |
| James R. Hale                                                  | 63,728,989 | (6) | 22.7% |
| PCF 1, LLC (7)                                                 | 61,731,172 |   | 22.0% |
| David Kronfeld                                                 | 38,954,987 | (8) | 13.9% |
| AvantaLion LLC (9)                                             | 22,820,650 |   | 8.1% |
| JK&B Capital V, L.P. (10)                                  | 20,592,850 |   | 7.3% |
| JK&B Capital V Special Opportunity Fund, L.P. (10)    | 15,534,956 |   | 5.5% |
| Roy E. Reichbach                                               | 7,193,682 | (11) | 2.6% |
| Michael (Horngwei) Her                                         | 4,822,150 | (12) | 1.7% |
| Ronald Nunn                                                    | 4,808,048 | (13) | 1.7% |
| J. Christopher Wagner                                          | 2,741,771 | (14) | 1.0% |
| Parallax Capital Fund, L.P. (7)                                | 1,747,000 |   | * |
| Gabriel A. Battista                                            | 760,067 | (15) | * |
| Shirley Strum Kenny                                            | 748,989 | (16) | * |
| John A. Coelho                                                 | 211,076 |   | * |
| Robert E. Bostrom                                              | 121,716 |   | * |
| Edward G. Goren                                                | 25,020 |   | * |
|                                                           |   |   |   |
| All current directors and executive officers (15 persons)      | 206,017,950 |   | 73.3% |

| (1) | Unless otherwise indicated, the address of such individual is c/o NeuLion, Inc., 1600 Old Country Road, Plainview, New York 11803. |
|-----|------------------------------------------------------------------------------------------------------------------------------------|

| (2) | The total number of shares beneficially owned includes shares over which the named person could have acquired voting power or investment power within 60 days after April 16, 2018. |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (3) | Based upon 280,334,268 shares of Common Stock outstanding as of April 16, 2018. |
|-----|---------------------------------------------------------------------------------|

| (4) | Includes (i) 56,040 shares of Common Stock held indirectly by two trusts for the benefit of Ms. Li’s children for which Ms. Li is the trustee, (ii) 1,999,664 shares of Common Stock underlying options and RSU Awards and (iii) 37,812,697 shares of Common Stock beneficially owned by Mr. Wang, Ms. Li’s spouse, of which Ms. Li disclaims beneficial ownership. See Footnote (5) below. |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (5) | Includes (i) 22,820,650 shares of Common Stock held by AvantaLion LLC (“AvantaLion”), a limited liability company controlled by Mr. Wang, (ii) 256,040 shares of Common Stock held indirectly by two trusts for the benefit of Mr. Wang’s grandchildren, for which Mr. Wang is the trustee and (iii) 43,405,760 shares of Common Stock beneficially owned by Ms. Li, Mr. Wang’s spouse. Excludes (i) 15,534,956 shares of Common Stock owned by JK&B Capital V Special Opportunity Fund, L.P. (“JK&B SOF”), an entity in which Mr. Wang has an 85% pecuniary interest and (ii) 5,000,000 shares of Common Stock held by a trust for the benefit of Mr. Wang’s children (the “2012 Trust”). Mr. Wang does not have voting or dispositive power over the shares held by Ms. Li, JK&B SOF, or the 2012 Trust and disclaims beneficial ownership of all such shares. |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (6) | Includes 61,731,172 shares of Common Stock controlled by PCF 1, LLC (“PCF”) and 1,747,000 shares of Common Stock controlled by Parallax Capital Fund, L.P.  Mr. Hale is the managing member of Parallax Holdings, LLC, which is the general partner of Parallax Capital, L.P., which is the general partner of Parallax Capital Fund, L.P., which is a limited liability company member of PCF.  Mr. Hale may be deemed to be the indirect beneficial owner of the reported securities by virtue of his indirect control of Parallax Capital Fund, L.P. and PCF.  Mr. Hale disclaims beneficial ownership of the reported securities to the extent such beneficial ownership exceeds his pecuniary interests therein. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (7) | The address of this beneficial owner is 23332 Mill Creek Dr., Suite 155, Laguna Hills, California 92653.  This beneficial owner is controlled by Mr. Hale.  See Footnote (6) above. |
|-----|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (8) | Includes 2,006,300 shares of Common Stock directly owned by DKB JTV Holdings, LLC, an entity controlled by Mr. Kronfeld.  Mr. Kronfeld disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.  Also includes (i) 20,592,850 shares of Common Stock directly owned by JK&B Capital V, L.P. (“JK&B”) and (ii) 15,534,956 shares of Common Stock directly owned by JK&B SOF. Mr. Kronfeld is the managing member of JK&B Capital V, L.L.C., the general partner of JK&B Management V, L.P. (“JK&B Management”). JK&B Management is the general partner of both JK&B and JK&B SOF. Mr. Kronfeld, JK&B Capital V, L.L.C. and JK&B Management each may be deemed to have sole voting and dispositive power over the shares.  Mr. Kronfeld disclaims beneficial ownership of the Common Stock owned by JK&B and JK&B SOF except to the extent of his pecuniary interest therein. |
|-----|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

| (9)  | AvantaLion is a limited liability company controlled by Mr. Wang.  See Footnote (5) above. |
|-----------|-------------------------------------------------------------------------------------------------|

| (10) | The address of this beneficial owner is c/o JK&B Capital, Two Prudential Plaza, 180 N. Stetson Avenue, Suite 4500, Chicago, Illinois 60601.  This beneficial owner is controlled by Mr. Kronfeld.  See Footnote (8) above. |
|------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (11) | Includes (i) 1,187,164 shares of Common Stock underlying options and RSU Awards and (ii) 5,000,000 shares of Common Stock held by the 2012 Trust.  Mr. Reichbach is the trustee of the 2012 Trust and in such capacity has voting and dispositive control with respect to such shares.  Mr. Reichbach disclaims beneficial ownership of the shares held by the 2012 Trust. |
|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (12) | Includes (i) 1,549,731 shares of Common Stock underlying options and RSU Awards and (ii) 6,000 shares of Common Stock owned by Mr. Her’s wife. |
|------|------------------------------------------------------------------------------------------------------------------------------------------------------|

| (13) | Includes 1,549,731 shares of Common Stock underlying options and RSU Awards. |
|------|------------------------------------------------------------------------------|

| (14) | Includes 1,199,731 shares of Common Stock underlying options and RSU Awards. |
|------|------------------------------------------------------------------------------|

| (15) | Includes (i) 100,000 shares of Common Stock underlying options and (ii) 660,067 shares of Common Stock held by the Gabriel A Battista TR UA 08/22/2006 Gabriel A Battista Revocable Trust. |
|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (16) | Held by the Shirley Kenny Revocable Trust UAD 03/11/2010. |
|------|-----------------------------------------------------------|

|                                     |   | Number of         |       |   |                 |   |   | Number of securities    |   |
|------------------------------------------|--------|-------------------|------------|--------|----------------------|--------|--------|-------------------------|--------|
|                                     |   | securities to be  |       |   |                 |   |   | remaining available for |   |
|                                     |   | issued upon       |       |   |                 |   |   | future issuance under   |   |
|                                     |   | exercise of       |       |   | Weighted-average     |   |   | equity compensation     |   |
|                                     |   | outstanding       |       |   | exercise price of    |   |   | plans (excluding        |   |
|                                     |   | options, warrants |       |   | outstanding options, |   |   | securities reflected in |   |
| Plan Category                            |   | and rights(5)     |       |   | warrants and rights  |   |   | column (a))             |   |
|                                     |   | (a)               |       |   | (b)                  |   |   | (c)                     |   |
| Equity compensation plans                |   |              |       |   |                 |   |   |                    |   |
| approved by security holders             |   |              |       |   |                 |   |   |                    |   |
|                                     |   |              |       |   |                 |   |   |                    |   |
| Amended and Restated NeuLion, Inc. 2012  |   |              | 33,756,900 |   |                 | $      | 0.45   |                    |   |   | 10,875,124 |   |
| Omnibus Securities and Incentive Plan(1) |   |              |       |   |                 |   |   |                    |   |   |   |   |
|                                     |   |              |       |   |                 |   |   |                    |   |   |   |   |
| Fourth Amended and Restated Stock        |   |              | 1,293,750  |   |                 | $      | 0.18   |                    |   |   | N/A |   |
| Option Plan(2)                           |   |              |       |   |                 |   |   |                    |   |   |   |   |
|                                     |   |              |       |   |                 |   |   |                    |   |   |   |   |
| Amended and Restated Directors’    |   |              | 0          |   |                 |   | N/A    |                    |   |   | 1,141,880 |   |
| Compensation Plan(3)                     |   |              |       |   |                 |   |   |                    |   |   |   |   |
|                                     |   |              |       |   |                 |   |   |                    |   |   |   |   |
| Employee Share Purchase Plan(4)          |   |              | N/A        |   |                 | NA     |   |                    |   | N/A |   |
|                                     |   |              |       |   |                 |   |   |                    |   |   |   |   |
| Equity compensation plans not            |   |              | N/A        |   |                 |   | N/A    |                    |   |   | N/A |   |
| approved by security holders             |   |              |       |   |                 |   |   |                    |   |   |   |   |
|                                     |   |              |       |   |                 |   |   |                    |   |   |   |   |
| Total                                    |   |              | 35,050,650 |   |                 | $      | 0.44   |                    |   |   | 12,017,004 |   |

| (1) | The maximum number of shares of Common Stock issuable upon exercise of securities granted pursuant to the 2012 Plan is 50,000,000. |
|-----|------------------------------------------------------------------------------------------------------------------------------------|

| (2) | The maximum number of shares of Common Stock issuable upon exercise of options granted pursuant to the Stock Option Plan is equal to the greater of (i) 4,000,000 shares of Common Stock and (ii) 12.5% of the number of issued and outstanding shares of Common Stock from time to time.  As a result, any increase in the issued and outstanding shares will result in an increase in the number of shares of Common Stock available for issuance under the Stock Option Plan, and any exercises of options will make new grants available under the Stock Option Plan.  No new option awards will be made under the Stock Option Plan; however, outstanding awards under the Stock Option Plan will remain in effect pursuant to their terms.  All awards of options are currently made under the 2012 Plan. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (3) | Shares of Common Stock are issued directly under the Directors’ Compensation Plan without exercise of any option, warrant or right. |
|-----|-------------------------------------------------------------------------------------------------------------------------------------------|

| (4) | We have not issued shares under the Employee Share Purchase Plan since its approval by our stockholders. |
|-----|----------------------------------------------------------------------------------------------------------|

| (5) | This column reflects grants of options and RSU Awards, including performance-based RSU Awards. |
|-----|------------------------------------------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

|  | · | modify the limits with respect to the maximum number of shares of Common Stock reserved for grant under the 2012 Plan; |
|--|--------|------------------------------------------------------------------------------------------------------------------------|

|  | · | amend the article of the 2012 Plan addressing amendments and terminations; |
|--|--------|----------------------------------------------------------------------------|

|  | · | amend, modify or suspend certain repricing prohibitions of the 2012 Plan, including reducing the exercise price of an award which is an Option benefiting an insider; |
|--|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | · | extend the term of an award which is an Option benefiting an insider; |
|--|--------|-----------------------------------------------------------------------|

|  | · | disproportionately increase the benefits accruing to insiders; or |
|--|--------|-------------------------------------------------------------------|

|  | · | amend the limits with respect to insiders set forth in the 2012 Plan. |
|--|--------|-----------------------------------------------------------------------|

----

Table of Contents

|  | · | The Holder’s rights, if any, to exercise any then exercisable NQSOs and/or SARs shall terminate: |
|--|--------|--------------------------------------------------------------------------------------------------------|

|  | o | If such termination is for a reason other than the Holder’s Total and Permanent Disability or death, three months after the date of such termination of employment or after the date of such termination of Director status; |
|--|---|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | o | If such termination is on account of the Holder’s Total and Permanent Disability, one year after the date of such termination of employment or Director status; or |
|--|---|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | o | If such termination is on account of the Holder’s death, one year after the date of the Holder’s death. |
|--|---|---------------------------------------------------------------------------------------------------------------------|

|  | · | The Holder’s rights, if any, to exercise any then exercisable ISO shall terminate: |
|--|--------|------------------------------------------------------------------------------------------|

|  | o | If such termination is for a reason other than the Holder’s Total and Permanent Disability or death, three months after the date of such termination of employment; |
|--|---|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | o | If such termination is on account of the Holder’s Total and Permanent Disability, one year after the date of such termination of employment; or |
|--|---|-------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | o | If such termination is on account of the Holder’s death, one year after the date of the Holder’s death. |
|--|---|---------------------------------------------------------------------------------------------------------------------|

|  | · | If a Holder’s employment with, or status as a Director of, the Company or an Affiliate, as applicable, terminates for any reason prior to the actual or deemed satisfaction and/or lapse of the Restrictions, vesting requirements, terms and conditions applicable to a Restricted Stock Award and/or Restricted Stock Unit Award, such Restricted Stock and/or Restricted Stock Units shall immediately be canceled, and the Holder (and such Holder’s estate, designated beneficiary or other legal representative) shall forfeit any rights or interests in and with respect to any such Restricted Stock and/or Restricted Stock Units. The immediately preceding sentence to the contrary notwithstanding, the Committee, in its sole discretion, may determine, prior to or within 30 days after the date of such termination of employment or Director status, that all or a portion of any such Holder’s Restricted Stock and/or Restricted Stock Units shall not be so canceled and forfeited. |
|--|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | · | The Holder’s rights, if any, to exercise any then exercisable NQSOs and/or SARs shall terminate: |
|--|--------|--------------------------------------------------------------------------------------------------------|

|  | o | If such termination is for a reason other than the Holder’s death, three months after the date of such termination; or |
|--|---|------------------------------------------------------------------------------------------------------------------------------|

|  | o | If such termination is on account of the Holder’s death, one year after the date of the Holder’s death. |
|--|---|---------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

|  | · | If the status of a Holder as a Consultant terminates for any reason prior to the actual or deemed satisfaction and/or lapse of the Restrictions, vesting requirements, terms and conditions applicable to a Restricted Stock Award and/or Restricted Stock Unit Award, such Restricted Stock and/or Restricted Stock Units shall immediately be canceled, and the Holder (and such Holder’s estate, designated beneficiary or other legal representative) shall forfeit any rights or interests in and with respect to any such Restricted Stock and/or Restricted Stock Units. The immediately preceding sentence to the contrary notwithstanding, the Committee, in its sole discretion, may determine, prior to or within 30 days after the date of such termination of such a Holder’s status as a Consultant, that all or a portion of any such Holder’s Restricted Stock and/or Restricted Stock Units shall not be so canceled and forfeited. |
|--|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

----

Table of Contents

|  | · | The excess of (i) the Fair Market Value of a share of the Common Stock on the date of exercise, over (ii) the Base Value, multiplied by |
|--|--------|-----------------------------------------------------------------------------------------------------------------------------------------|

|  | · | The number of shares of Common Stock with respect to which the SAR is exercised. |
|--|--------|----------------------------------------------------------------------------------|

|  | · | The Base Value shall be equal to or greater than the per share exercise price under the related Option; |
|--|--------|---------------------------------------------------------------------------------------------------------|

|  | · | The Tandem SAR may be exercised for all or part of the shares of Common Stock which are subject to the related Option, but solely upon the surrender by the Holder of the Holder’s right to exercise the equivalent portion of the related Option (and when a share of Common Stock is purchased under the related Option, an equivalent portion of the related Tandem SAR shall be cancelled); |
|--|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | · | The Tandem SAR shall expire no later than the date of the expiration of the related Option; |
|--|--------|---------------------------------------------------------------------------------------------|

|  | · | The value of the payment with respect to the Tandem SAR may be no more than 100% of the difference between the per share exercise price under the related Option and the Fair Market Value of the shares of Common Stock subject to the related Option at the time the Tandem SAR is exercised, multiplied by the number of shares of Common Stock with respect to which the Tandem SAR is exercised; and |
|--|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | · | The Tandem SAR may be exercised solely when the Fair Market Value of a share of Common Stock subject to the related Option exceeds the per share exercise price under the related Option. |
|--|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

|  | · | providing Eligible Persons (as defined below) with additional incentives; |
|--|--------|---------------------------------------------------------------------------|

|  | · | encouraging stock ownership by Eligible Persons; |
|--|--------|--------------------------------------------------|

|  | · | increasing the proprietary interest of Eligible Persons in the success of the Company; |
|--|--------|----------------------------------------------------------------------------------------|

|  | · | encouraging Eligible Persons to remain loyal to the Company or a related entity; and |
|--|--------|--------------------------------------------------------------------------------------|

|  | · | attracting new employees, officers, directors and consultants to the Company or a related entity. |
|--|--------|---------------------------------------------------------------------------------------------------|

|  | · | If the Common Stock trades on a market, |
|--|--------|-----------------------------------------|

|  | o | the exercise price is based on the closing market price of the Common Stock on the market with the largest trading volume of the Common Stock on the last trading date preceding the date of the grant; and |
|--|---|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | o | if there is no trading on that date, the exercise price will be the average of the bid and ask on the date preceding the date of the grant. |
|--|---|---------------------------------------------------------------------------------------------------------------------------------------------|

|  | · | If there is no trading market for the Common Stock, the Board will in good faith determine the exercise price of an option based on the fair market value of the Common Stock on the date of the grant. |
|--|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | · | If the option is to be granted on a pre-determined date in the future, the exercise price will be the weighted average trading price, rounding up to the nearest cent, of the Common Stock on the stock exchange or quotation system upon which any shares of the Company are then listed and posted or quoted for trading for the five trading dates preceding the date of the grant. |
|--|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | · | In all instances the exercise price shall not be less than the fair market value as determined by IRC Section 409A. |
|--|--------|---------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

|  | · | 10% of the shares of Common Stock outstanding under all share compensation arrangements; |
|--|--------|------------------------------------------------------------------------------------------|

|  | · | 10% of the shares of Common Stock outstanding issuable to insiders within a one-year period; and |
|--|--------|--------------------------------------------------------------------------------------------------|

|  | · | 5% of the shares of Common Stock outstanding issuable to any one insider within a one-year period. |
|--|--------|----------------------------------------------------------------------------------------------------|

|  | · | to increase the maximum number of shares of Common Stock that may be issued pursuant to options granted under the Stock Option Plan; |
|--|--------|--------------------------------------------------------------------------------------------------------------------------------------|

|  | · | to reduce the exercise price of options for the benefit of an insider; |
|--|--------|------------------------------------------------------------------------|

|  | · | to extend the expiry date of options for the benefit of an insider; and |
|--|--------|-------------------------------------------------------------------------|

|  | · | to amend the section of the Stock Option Plan that addresses these types of amendments. |
|--|--------|-----------------------------------------------------------------------------------------|

|  | · | issue shares of Common Stock to non-executive directors under the Directors’ Compensation Plan; |
|--|--------|-------------------------------------------------------------------------------------------------------|

----

Table of Contents

|  | · | determine the terms, including the limitations, restrictions and conditions, if any, upon such grants; |
|--|--------|--------------------------------------------------------------------------------------------------------|

|  | · | interpret the Directors’ Compensation Plan and adopt, amend and rescind such administrative guidelines and other rules and regulations relating to the Directors’ Compensation Plan as it may from time to time deem advisable, subject to required prior approval by any applicable regulatory authority; |
|--|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | · | suspend or terminate the Directors’ Compensation Plan; and |
|--|--------|------------------------------------------------------------------|

|  | · | make all other determinations and take all other actions in connection with the implementation and administration of the Directors’ Compensation Plan as it may deem necessary or advisable. |
|--|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | · | amendments as may be necessary to comply with applicable law or the requirements of any applicable regulatory authority or stock exchange; |
|--|--------|--------------------------------------------------------------------------------------------------------------------------------------------|

|  | · | an amendment to correct or rectify any ambiguity, defective provision, error or omission in the ESPP; |
|--|--------|-------------------------------------------------------------------------------------------------------|

|  | · | an amendment to change the provisions relating to the administration of the ESPP; and |
|--|--------|---------------------------------------------------------------------------------------|

|  | · | to make any other amendment to the ESPP that does not require stockholder approval by virtue of the provisions of the ESPP, applicable laws or relevant regulatory or stock exchange requirements. |
|--|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

|  | · | the number of whole Common Stock credited to his or her account; or |
|--|--------|---------------------------------------------------------------------|

|  | · | the cash equivalent of the value of the whole Common Stock to his or her account, less any brokerage fees, as determined by the administrator, as of the date of termination of employment, retirement, death or withdrawal from the ESPP, whichever the case may be. |
|--|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

| ITEM 13. | Certain Relationships and Related Transactions, and Director Independence |
|----------|---------------------------------------------------------------------------|

|               |   | As of December 31, |   |
|--------------------|--------|--------------------|--------|
|               |   | 2017               |   |   | 2016 |   |
| New York Islanders |   | $                  | 3,431  |   |   | $ | 102,477 |   |
| Renaissance        |   |               | (5,925 | ) |   |   | 25,904 |   |
| KyLin TV           |   |               | 70,185 |   |   |   | 422,408 |   |
| Smile Train        |   |               | 24,000 |   |   |   | 0 |   |
|               |   | $                  | 91,691 |   |   | $ | 550,789 |   |

|  | · | grants PCF certain registration rights with respect to shares of our Common Stock; |
|--|--------|------------------------------------------------------------------------------------|

|  | · | grants PCF a preemptive right to participate in sales of our securities by us, subject to specified exceptions, to PCF; |
|--|--------|-------------------------------------------------------------------------------------------------------------------------|

|  | · | obligates us to deliver periodic financial statements to PCF and grants PCF certain inspection rights; |
|--|--------|--------------------------------------------------------------------------------------------------------|

----

Table of Contents

|  | · | entitles PCF to designate two members of the Board, at least one of whom will serve on each of the Audit, Compensation and Nominating Committees, along with an agreement by Mr. Wang, Ms. Li and AvantaLion to vote in favor of such designees; and |
|--|--------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | · | grants PCF approval rights with respect to certain key stockholder transaction and liquidation events. |
|--|--------|--------------------------------------------------------------------------------------------------------|

----

Table of Contents

|  | · | A majority of the Board is comprised of non-executive directors.  The only members of management on the Board are the Executive Chair and the President and Chief Executive Officer of the Company.  While Mr. Wang is not “independent” as defined by NASDAQ Listing Rule 5605, he is not a member of management of the Company and is therefore considered to be a non-executive director. |
|--|--------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | · | A Lead Independent Director, currently Mr. Kronfeld, provides overall leadership to the Board and ensures that the Board’s agenda will enable it to successfully carry out its duties.  Mr. Kronfeld is familiar with the mandate of the Board and the charters of the Board committees and acts as chair of or serves on any ad hoc special committee established by the Board. |
|--|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | · | Independent, non-executive directors meet periodically without management present. |
|--|--------|------------------------------------------------------------------------------------|

|  | · | Members of management, including the Executive Chair and the President and Chief Executive Officer, are not present for the discussion and determination of certain matters at meetings of the Board. |
|--|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | · | The President and Chief Executive Officer’s compensation is recommended by the Compensation Committee, which is comprised entirely of independent directors.  The President and Chief Executive Officer is not present at these deliberations. |
|--|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| ITEM 14. | Principal Accounting Fees and Services |
|----------|----------------------------------------|

|  | · | The Audit Committee approves the annual audit services engagement and, if necessary, any changes in terms, conditions and fees resulting from changes in audit scope, company structure or other matters. As discussed above, the Audit Committee may also pre-approve other audit services, which are those services that only the independent registered public accountants reasonably can provide. |
|--|--------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | · | The Audit Committee believes that the provision of audit-related services does not impair the independence of the independent registered public accountants. Audit-related services are assurance and related services that are reasonably related to the performance of the audit, and that are traditionally performed by the independent registered public accountants. |
|--|--------|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | · | The Audit Committee believes that, in appropriate cases, the independent registered public accountants can provide tax compliance services, tax planning and tax advice without impairing the auditors’ independence. |
|--|--------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|  | · | The Audit Committee may approve other services to be provided by the independent registered public accountants if (i) the services are permissible under SEC and Public Company Accounting Oversight Board rules, (ii) the Audit Committee believes the provision of the services would not impair the independence of the independent registered public accountants and (iii) management believes that the independent registered public accountants are the best choice to provide the service. |
|--|--------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

Table of Contents

|                  |   | 2017 $ |    |   | 2016 $ |   |
|-----------------------|--------|--------|---------|--------|--------|--------|
| Audit fees(1)         |   |   | 490,000 |   |   |   | 457,000 |   |
| Audit-related fees(2) |   |   | 11,000  |   |   |   | - |   |
| Tax fees(3)           |   |   | 94,000  |   |   |   | 100,300 |   |
| All other fees(4)     |   |   | 130,000 |   |   |   | 90,000 |   |
| Total                 |   |   | 725,000 |   |   |   | 647,300 |   |

| (1) | In 2017, audit fees were for audit services.  In 2016, audit fees were comprised of $450,000 for audit services and $7,000 for rendering a consent in connection with the Company’s Registration Statement on Form S-8. |
|-----|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (2) | In 2017, audit-related fees were for transaction-related services. |
|-----|--------------------------------------------------------------------|

| (3) | In 2017, tax fees were comprised of $90,000 for professional services rendered for the preparation of the Company’s tax returns and $4,000 for miscellaneous tax services.  In 2016, tax fees were comprised of $90,000 for professional services rendered for the preparation of the Company’s tax returns and $10,300 for miscellaneous tax services. |
|-----|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (4) | In each of 2017 and 2016, the fees were for an examination and report regarding the Company’s Service Organization Controls. |
|-----|------------------------------------------------------------------------------------------------------------------------------------|

| ITEM 15. | Exhibits, Financial Statement Schedules |
|----------|-----------------------------------------|

| (a) | (1)           | Financial Statements:  Included in Part II, Item 8 of the Original Form 10-K |
|-----|-----------------------------------------------------------------|-----------------------------------------------------------------------------------|

|  | (2)           | Financial Statement Schedules:  Included in Part IV of the Original Form 10-K |
|--|-----------------------------------------------------------------|------------------------------------------------------------------------------------|

| (b) | Exhibits |
|-----|----------|

| Exhibit No. | Description                                                                                                                                                                                                                                                                                                                                                                                                                             |
|-------------|-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|        |                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 2.1         | Agreement and Plan of Merger dated as of January 2, 2015 by and among NeuLion, Inc., NLDMC, Inc., NLDAC, Inc., PCF 1, LLC and DivX Corporation (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed January 5, 2015)                                                                                                                                                                      |
|        |                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 3.1         | Certificate of Domestication (incorporated by reference to Exhibit 3.1 to the Company’s Current Report on Form 8-K filed December 6, 2010)                                                                                                                                                                                                                                                                                        |
|        |                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 3.2         | Corrected Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3(i) to the Company’s Quarterly Report on Form 10-Q filed November 1, 2017)                                                                                                                                                                                                                                                     |
|        |                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 3.3         | Amended and Restated Bylaws (incorporated by reference to Exhibit 3(ii) to the Company’s Current Report on Form 8-K filed March 27, 2018)                                                                                                                                                                                                                                                                                         |
|        |                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 4.1         | Form of stock specimen (incorporated by reference to Exhibit 4.1 to the Company’s Annual Report on Form 10-K filed March 1, 2017)                                                                                                                                                                                                                                                                                                 |
|        |                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 9.1         | Stockholders’ Agreement dated January 2015 by and among NeuLion, Inc., PCF 1, LLC and each of the persons listed on Exhibit B thereto (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed February 2, 2015 and originally included as Exhibit C to the Agreement and Plan of Merger filed as Exhibit 10.1 to the Company’s Current Report on Form 8-K filed January 5, 2015) |

----

Table of Contents

| 10.1#     | Fourth Amended and Restated Stock Option Plan, as amended (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K filed November 12, 2013)                 |
|-----------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
|      |                                                                                                                                                                                            |
| 10.2#     | Amended and Restated Directors’ Compensation Plan, as amended (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K filed June 5, 2012)            |
|      |                                                                                                                                                                                            |
| 10.3#     | Employee Share Purchase Plan (incorporated by reference to Exhibit 10.17 to the Company’s Registration Statement on Form 10 filed April 9, 2009)                                          |
|      |                                                                                                                                                                                            |
| 10.4#     | Amended and Restated NeuLion, Inc. 2012 Omnibus Securities and Incentive Plan (incorporated by reference to Exhibit 10.8 to the Company’s Annual Report on Form 10-K filed March 1, 2017) |
|      |                                                                                                                                                                                            |
| 10.5#     | Form of Stock Option Agreement (incorporated by reference to Exhibit 10.10 to the Company’s Annual Report on Form 10-K filed March 1, 2017)                                               |
|      |                                                                                                                                                                                            |
| 10.6#     | Form of Restricted Stock Unit Award Agreement (incorporated by reference to Exhibit 10.11 to the Company’s Annual Report on Form 10-K filed March 1, 2017)                                |
|      |                                                                                                                                                                                            |
| 21**      | Subsidiaries                                                                                                                                                                                    |
|      |                                                                                                                                                                                            |
| 23.1**    | Consent of EisnerAmper LLP                                                                                                                                                                      |
|      |                                                                                                                                                                                            |
| 31.1*     | Certification of the Chief Executive Officer (Principal Executive Officer) pursuant to Rule 13a-14(a) of the Exchange Act                                                                       |
|      |                                                                                                                                                                                            |
| 31.2*     | Certification of the Chief Financial Officer (Principal Financial Officer) pursuant to Rule 13a-14(a) of the Exchange Act                                                                       |
|      |                                                                                                                                                                                            |
| 32**      | Certification pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002                                                                                  |
|      |                                                                                                                                                                                            |
| 101.INS** | XBRL Instance Document                                                                                                                                                                          |
|      |                                                                                                                                                                                            |
| 101.SCH** | XBRL Taxonomy Extension Schema Document                                                                                                                                                         |
|      |                                                                                                                                                                                            |
| 101.CAL** | XBRL Taxonomy Extension Calculation Linkbase Document                                                                                                                                           |
|      |                                                                                                                                                                                            |
| 101.DEF** | XBRL Taxonomy Extension Definition Linkbase Document                                                                                                                                            |
|      |                                                                                                                                                                                            |
| 101.LAB** | XBRL Taxonomy Extension Label Linkbase Document                                                                                                                                                 |
|      |                                                                                                                                                                                            |
| 101.PRE** | XBRL Taxonomy Extension Presentation Linkbase Document                                                                                                                                          |

| # | Management contract or compensatory plan or arrangements |
|---|----------------------------------------------------------|

| * | Filed herewith |
|---|----------------|

| ** | Previously filed with the Original Form 10-K, which is amended hereby |
|----|-----------------------------------------------------------------------|

----

Table of Contents

|           | NEULION, INC. |
|----------------|---------------|
|           |          |
|           |          |
| April 25, 2018 | By:           | /s/ Roy E. Reichbach |
|           |          | Name:   | Roy E. Reichbach |
|           |          | Title: | President and Chief Executive Officer |
|           |          |   | (Principal Executive Officer) |

----